Exploration of the Molecular Basis of Forsythia Fruit in the Prevention and Treatment of Cholestatic Liver Injury through Network Pharmacology and Molecular Docking

Forsythia fruit, edible fruit of (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for alleviating cholestasis has not been determined. In this study, four representative active ingredients in forsythia fruit were selected. Through network pharma...

Full description

Saved in:
Bibliographic Details
Published inNutrients Vol. 15; no. 9; p. 2065
Main Authors Fu, Ke, Li, Yanzhi, Dai, Shu, Li, Yunxia
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 25.04.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Forsythia fruit, edible fruit of (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for alleviating cholestasis has not been determined. In this study, four representative active ingredients in forsythia fruit were selected. Through network pharmacology and molecular docking technology, we tried to find the key component for its treatment of cholestasis. Furthermore, the model of cholestasis in mice was established to verify the protective effect of the key component on cholestasis. Network pharmacology and molecular docking showed that forsythoside A (FTA) is the key component of forsythia fruit in the treatment of cholestasis. In vivo experiments revealed that FTA treatment could alleviate liver injury, dysfunction, and collagen deposition induced by cholestasis in mice. At the same time, FTA treatment inhibited inflammatory factor release and fibrosis-related factor expression. In addition, FTA treatment also reduced MMP-2, TLR4, MYD88, NF-κB p65, and -NF-κB p65 protein expression. In conclusion, FTA, a key component of forsythia fruit, alleviated liver damage and fibrosis caused by cholestasis via inhibiting the TLR4/NF-κB pathway, extracellular matrix accumulation, and inflammatory cytokine expression. The research results could provide a scientific reference for the development of forsythia fruit as a drug or functional food to prevent and treat cholestasis.
AbstractList Forsythia fruit, edible fruit of Forsythia suspensa (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for alleviating cholestasis has not been determined. In this study, four representative active ingredients in forsythia fruit were selected. Through network pharmacology and molecular docking technology, we tried to find the key component for its treatment of cholestasis. Furthermore, the model of cholestasis in mice was established to verify the protective effect of the key component on cholestasis. Network pharmacology and molecular docking showed that forsythoside A (FTA) is the key component of forsythia fruit in the treatment of cholestasis. In vivo experiments revealed that FTA treatment could alleviate liver injury, dysfunction, and collagen deposition induced by cholestasis in mice. At the same time, FTA treatment inhibited inflammatory factor release and fibrosis-related factor expression. In addition, FTA treatment also reduced MMP-2, TLR4, MYD88, NF-κB p65, and p-NF-κB p65 protein expression. In conclusion, FTA, a key component of forsythia fruit, alleviated liver damage and fibrosis caused by cholestasis via inhibiting the TLR4/NF-κB pathway, extracellular matrix accumulation, and inflammatory cytokine expression. The research results could provide a scientific reference for the development of forsythia fruit as a drug or functional food to prevent and treat cholestasis.
Forsythia fruit, edible fruit of (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for alleviating cholestasis has not been determined. In this study, four representative active ingredients in forsythia fruit were selected. Through network pharmacology and molecular docking technology, we tried to find the key component for its treatment of cholestasis. Furthermore, the model of cholestasis in mice was established to verify the protective effect of the key component on cholestasis. Network pharmacology and molecular docking showed that forsythoside A (FTA) is the key component of forsythia fruit in the treatment of cholestasis. In vivo experiments revealed that FTA treatment could alleviate liver injury, dysfunction, and collagen deposition induced by cholestasis in mice. At the same time, FTA treatment inhibited inflammatory factor release and fibrosis-related factor expression. In addition, FTA treatment also reduced MMP-2, TLR4, MYD88, NF-κB p65, and -NF-κB p65 protein expression. In conclusion, FTA, a key component of forsythia fruit, alleviated liver damage and fibrosis caused by cholestasis via inhibiting the TLR4/NF-κB pathway, extracellular matrix accumulation, and inflammatory cytokine expression. The research results could provide a scientific reference for the development of forsythia fruit as a drug or functional food to prevent and treat cholestasis.
Forsythia fruit, edible fruit of Forsythia suspensa (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for alleviating cholestasis has not been determined. In this study, four representative active ingredients in forsythia fruit were selected. Through network pharmacology and molecular docking technology, we tried to find the key component for its treatment of cholestasis. Furthermore, the model of cholestasis in mice was established to verify the protective effect of the key component on cholestasis. Network pharmacology and molecular docking showed that forsythoside A (FTA) is the key component of forsythia fruit in the treatment of cholestasis. In vivo experiments revealed that FTA treatment could alleviate liver injury, dysfunction, and collagen deposition induced by cholestasis in mice. At the same time, FTA treatment inhibited inflammatory factor release and fibrosis-related factor expression. In addition, FTA treatment also reduced MMP-2, TLR4, MYD88, NF-κB p65, and p -NF-κB p65 protein expression. In conclusion, FTA, a key component of forsythia fruit, alleviated liver damage and fibrosis caused by cholestasis via inhibiting the TLR4/NF-κB pathway, extracellular matrix accumulation, and inflammatory cytokine expression. The research results could provide a scientific reference for the development of forsythia fruit as a drug or functional food to prevent and treat cholestasis.
Audience Academic
Author Li, Yunxia
Li, Yanzhi
Fu, Ke
Dai, Shu
AuthorAffiliation State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; fuke1993@stu.cdutcm.edu.cn (K.F.); liyanzhi@stu.cdutcm.edu.cn (Y.L.)
AuthorAffiliation_xml – name: State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; fuke1993@stu.cdutcm.edu.cn (K.F.); liyanzhi@stu.cdutcm.edu.cn (Y.L.)
Author_xml – sequence: 1
  givenname: Ke
  surname: Fu
  fullname: Fu, Ke
  organization: State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
– sequence: 2
  givenname: Yanzhi
  surname: Li
  fullname: Li, Yanzhi
  organization: State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
– sequence: 3
  givenname: Shu
  surname: Dai
  fullname: Dai, Shu
  organization: State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
– sequence: 4
  givenname: Yunxia
  surname: Li
  fullname: Li, Yunxia
  organization: State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37432229$$D View this record in MEDLINE/PubMed
BookMark eNptktFu0zAUhiM0xEbZDQ-AInGDJnU4dhInV2h0K1QqsItxbZ04duIusYuTFPo-PCgn7ehWRHyR6Pj_P-f8Pi-DE-usCoLXEblkLCfv7RAlJKckTZ4FZ5RwOk3TmJ08-T4NzrtuRcaHE56yF8Ep4zGjlOZnwe-bX-vGeeiNs6HTYV-r8ItrlBwa8OFH6Ew3lufOd9u-NhDO_WD60Nid8tarjbI7L9gyvPMK-hYLo2VWI6brkSzDpdkoHy7savBbNHo3VHX4VfU_nb8Pb2vwLUjXuGq7wzyef-3kvbHVq-C5hqZT5w_vSfB9fnM3-zxdfvu0mF0tpzKJST_lmilgkcoIKSRhShacJrKQOk9UmcqU85wpKlXJChYRLVWRUV0QCpJnGAdjk2Cx55YOVmLtTQt-KxwYsSs4Xwnw2E-jhIQYcskimmR5DFJnCQOklppBihsaWR_2rPVQtKqUmIqH5gh6vGNNLSq3ERGJMpKmHAnvHgje_RgwStGaTqqmAavc0AmasZTmnOGVToK3_0hXbvAWs0JVRNMop_iDB1UF2IGx2uHBcoSKKx7nGECUjKrL_6hwlao1EodPG6wfGS72Buld13mlD01GRIwzKh5nFMVvnsZykP6dSPYH1knlpQ
CitedBy_id crossref_primary_10_1111_all_15967
crossref_primary_10_1002_jmr_3055
crossref_primary_10_1016_j_bbadis_2023_166822
crossref_primary_10_1016_j_jep_2023_117584
Cites_doi 10.1038/s41598-017-01171-y
10.1186/1758-2946-3-33
10.1139/cjpp-2015-0454
10.1152/ajpgi.90368.2008
10.1016/j.jep.2021.114829
10.1007/s10517-014-2455-7
10.5604/01.3001.0012.7860
10.1016/j.virusres.2007.09.008
10.1093/femsle/fnac052
10.1016/j.jep.2016.05.056
10.1016/j.biopha.2022.113185
10.3390/molecules22071135
10.1101/gr.1239303
10.1093/nar/gkz382
10.1002/jcc.21334
10.1016/j.jep.2020.113275
10.1016/j.bbadis.2021.166320
10.1002/hep.32437
10.1016/j.intimp.2019.106179
10.1101/cshperspect.a001651
10.1016/j.biochi.2021.06.001
10.1016/j.trsl.2009.03.007
10.1002/eji.1830260527
10.1016/j.jpedsurg.2022.08.020
10.1186/s12929-018-0475-8
10.1096/fj.201901046R
10.3389/fphar.2021.618522
10.1016/j.phymed.2022.154517
10.1007/s11255-009-9683-1
10.1016/j.tips.2021.11.004
10.1016/j.compbiolchem.2020.107402
10.1016/j.freeradbiomed.2022.02.007
10.18433/jpps32911
10.1093/nar/24.12.2236
10.1093/nar/gkn923
10.3389/fphar.2021.672054
10.1038/aps.2014.155
10.1111/fcp.12294
10.3390/nu13082901
10.1038/nchembio.118
10.1016/j.pt.2019.09.005
10.1038/labinvest.2010.61
10.2147/DDDT.S90030
10.1038/s41575-020-00372-7
10.3724/SP.J.1009.2013.00110
10.1016/j.mam.2018.09.002
10.1007/s10517-010-0810-x
10.1016/j.ijpharm.2022.121480
10.1038/nprot.2008.211
10.1056/NEJMoa1509840
10.1146/annurev-pharmtox-010818-021059
10.1074/jbc.M109910200
10.1007/s40265-021-01545-7
10.1038/srep41038
10.1016/j.jep.2021.113890
10.1002/hep.27744
10.1016/j.cgh.2007.05.008
10.1016/j.biotechadv.2018.02.002
10.1053/j.gastro.2010.09.004
10.1074/jbc.M104518200
10.3390/cells9020281
10.1016/j.intimp.2020.107328
10.1093/nar/gku477
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TS
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/nu15092065
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Physical Education Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
Physical Education Index
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
Publicly Available Content Database

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2072-6643
ExternalDocumentID oai_doaj_org_article_ca4a9c3125894acf853ab31df3a6a9cf
A749233155
10_3390_nu15092065
37432229
Genre Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81630101
– fundername: Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  grantid: ZYYCXTD-D-202209
– fundername: National Natural Science Foundation of China
  grantid: 81891012
– fundername: National Natural Science Foundation of China
  grantid: U19A2010
– fundername: Sichuan Province Science and Technology Support Program
  grantid: 2021JDRC0041
– fundername: National Natural Science Foundation of China
  grantid: 81891012; U19A2010; 81630101
– fundername: Sichuan Province Science and Technology Support Program
  grantid: 2021JDRC0041; 2022ZYD0088
– fundername: Sichuan TCM Science and Technology Industry Innovation Team
  grantid: 2022C001
GroupedDBID ---
3V.
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAWTL
ABUWG
ACIWK
ACPRK
AENEX
AFKRA
AFRAH
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
APEBS
ATCPS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
DIK
E3Z
EBD
ECGQY
ECM
EIF
EIHBH
ESTFP
EYRJQ
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
ITC
KQ8
LK8
M0K
M1P
M48
M7P
MODMG
M~E
NPM
OK1
OZF
P2P
P6G
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
UKHRP
AAYXX
CITATION
7TS
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
AFPKN
ID FETCH-LOGICAL-c540t-7f3ea31e800bc03ecb725cbcf95ed6c67793e2ced3b310fceb82fb02ac7832233
IEDL.DBID RPM
ISSN 2072-6643
IngestDate Mon Oct 07 19:33:47 EDT 2024
Tue Sep 17 21:32:20 EDT 2024
Wed Dec 04 04:47:10 EST 2024
Thu Oct 10 18:57:40 EDT 2024
Tue Nov 19 20:41:01 EST 2024
Tue Nov 12 23:17:34 EST 2024
Fri Dec 06 06:04:32 EST 2024
Wed Oct 16 00:38:40 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords forsythia fruit
molecular docking
forsythoside A
TLR4/NF-κB pathway
cholestasis
network pharmacology
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-7f3ea31e800bc03ecb725cbcf95ed6c67793e2ced3b310fceb82fb02ac7832233
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180667/
PMID 37432229
PQID 2812619285
PQPubID 2032353
ParticipantIDs doaj_primary_oai_doaj_org_article_ca4a9c3125894acf853ab31df3a6a9cf
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10180667
proquest_miscellaneous_2836297376
proquest_journals_2812619285
gale_infotracmisc_A749233155
gale_infotracacademiconefile_A749233155
crossref_primary_10_3390_nu15092065
pubmed_primary_37432229
PublicationCentury 2000
PublicationDate 2023-04-25
PublicationDateYYYYMMDD 2023-04-25
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-25
  day: 25
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Nutrients
PublicationTitleAlternate Nutrients
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Jiang (ref_26) 2021; 12
Nogales (ref_21) 2021; 43
Banck (ref_33) 2011; 3
ref_14
Rudra (ref_57) 2022; 181
Bennett (ref_72) 2009; 154
Song (ref_22) 2020; 80
ref_53
Fidchenko (ref_68) 2014; 156
Buyel (ref_9) 2018; 36
Aihaiti (ref_27) 2021; 12
Zong (ref_43) 2020; 51
Yu (ref_39) 2019; 23
Fickert (ref_45) 2010; 90
Wang (ref_66) 2017; 7
Trott (ref_34) 2010; 31
Zhang (ref_17) 2019; 34
Nickel (ref_28) 2014; 42
Haidl (ref_44) 1996; 26
Li (ref_20) 2013; 11
Meng (ref_16) 2015; 17
Fu (ref_35) 2022; 151
Jiao (ref_24) 2020; 90
Rysz (ref_56) 2011; 43
Yu (ref_62) 2015; 36
Wu (ref_58) 2016; 190
ref_23
Carmody (ref_46) 2007; 4
Mukhtar (ref_10) 2008; 131
Kushnareva (ref_69) 2009; 148
Zhao (ref_60) 2015; 9
Sen (ref_12) 2015; 147
Shannon (ref_30) 2003; 13
Zou (ref_7) 2021; 92
Parola (ref_54) 2019; 65
Kaftanovskaya (ref_71) 2019; 33
(ref_49) 2001; 276
Quelhas (ref_65) 2022; 58
Gong (ref_63) 2021; 271
Huang (ref_31) 2009; 4
Kisseleva (ref_55) 2020; 18
Zhang (ref_42) 2017; 31
Lawrence (ref_47) 2009; 1
Hopkins (ref_19) 2008; 4
Yuan (ref_25) 2022; 25
Jiang (ref_52) 2022; 1868
Xu (ref_18) 2021; 13
Cai (ref_38) 2022; 284
Xue (ref_36) 2023; 108
Abramicheva (ref_67) 2019; 84
Ibrahim (ref_5) 2022; 75
Hu (ref_15) 2020; 262
Wagner (ref_8) 2020; 60
Chen (ref_2) 2018; 25
Guo (ref_40) 2019; 18
Hasegawa (ref_3) 2021; 81
Burban (ref_61) 2017; 7
Ezhilarasan (ref_70) 2021; 187
Li (ref_59) 2018; 19
Nevens (ref_6) 2016; 375
Huang (ref_32) 2009; 37
Ghonem (ref_51) 2015; 62
Hirschfield (ref_1) 2010; 139
Correia (ref_48) 2002; 277
Zhou (ref_11) 2022; 369
Daina (ref_29) 2019; 47
Chen (ref_41) 2016; 94
Talman (ref_13) 2019; 35
Matthews (ref_50) 1996; 24
Moon (ref_64) 2009; 296
Heathcote (ref_4) 2007; 5
Yuan (ref_37) 2022; 615
References_xml – volume: 7
  start-page: 1815
  year: 2017
  ident: ref_61
  article-title: Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-01171-y
  contributor:
    fullname: Burban
– volume: 3
  start-page: 33
  year: 2011
  ident: ref_33
  article-title: Open babel: An open chemical toolbox
  publication-title: J. Cheminform.
  doi: 10.1186/1758-2946-3-33
  contributor:
    fullname: Banck
– volume: 94
  start-page: 402
  year: 2016
  ident: ref_41
  article-title: Resveratrol reduces matrix metalloproteinases and alleviates intrahepatic cholestasis of pregnancy in rats
  publication-title: Can. J. Physiol. Pharmacol.
  doi: 10.1139/cjpp-2015-0454
  contributor:
    fullname: Chen
– volume: 296
  start-page: G582
  year: 2009
  ident: ref_64
  article-title: Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient mice
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.90368.2008
  contributor:
    fullname: Moon
– volume: 284
  start-page: 114829
  year: 2022
  ident: ref_38
  article-title: Cultured bear bile powder ameliorates acute liver injury in cholestatic mice via inhibition of hepatic inflammation and apoptosis
  publication-title: J. Ethnopharmacol.
  doi: 10.1016/j.jep.2021.114829
  contributor:
    fullname: Cai
– volume: 156
  start-page: 803
  year: 2014
  ident: ref_68
  article-title: Effect of prolactin on the water-salt balance in rat females in the model of cholestasis of pregnancy
  publication-title: Bull. Exp. Biol. Med.
  doi: 10.1007/s10517-014-2455-7
  contributor:
    fullname: Fidchenko
– volume: 18
  start-page: 40
  year: 2019
  ident: ref_40
  article-title: Celastrol attenuates intrahepatic cholestasis of pregnancy by inhibiting matrix metalloproteinases-2 and 9
  publication-title: Ann. Hepatol.
  doi: 10.5604/01.3001.0012.7860
  contributor:
    fullname: Guo
– volume: 131
  start-page: 111
  year: 2008
  ident: ref_10
  article-title: Antiviral potentials of medicinal plants
  publication-title: Virus Res.
  doi: 10.1016/j.virusres.2007.09.008
  contributor:
    fullname: Mukhtar
– volume: 369
  start-page: fnac052
  year: 2022
  ident: ref_11
  article-title: Endophytic fungi and their bioactive secondary metabolites in medicinal leguminosae plants: Nearly untapped medical resources
  publication-title: FEMS Microbiol. Lett.
  doi: 10.1093/femsle/fnac052
  contributor:
    fullname: Zhou
– volume: 190
  start-page: 22
  year: 2016
  ident: ref_58
  article-title: Up-regulation of BSEP and MRP2 by Calculus Bovis administration in 17α-ethynylestradiol-induced cholestasis: Involvement of PI3K/Akt signaling pathway
  publication-title: J. Ethnopharmacol.
  doi: 10.1016/j.jep.2016.05.056
  contributor:
    fullname: Wu
– volume: 151
  start-page: 113185
  year: 2022
  ident: ref_35
  article-title: Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2022.113185
  contributor:
    fullname: Fu
– ident: ref_23
  doi: 10.3390/molecules22071135
– volume: 13
  start-page: 2498
  year: 2003
  ident: ref_30
  article-title: Cytoscape: A software environment for integrated models of Biomolecular Interaction Networks
  publication-title: Genome Res.
  doi: 10.1101/gr.1239303
  contributor:
    fullname: Shannon
– volume: 47
  start-page: W357
  year: 2019
  ident: ref_29
  article-title: Swiss target prediction: Updated data and new features for efficient prediction of protein targets of small molecules
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkz382
  contributor:
    fullname: Daina
– volume: 31
  start-page: 455
  year: 2010
  ident: ref_34
  article-title: AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.21334
  contributor:
    fullname: Trott
– volume: 262
  start-page: 113275
  year: 2020
  ident: ref_15
  article-title: Forsythiae fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways
  publication-title: J. Ethnopharmacol.
  doi: 10.1016/j.jep.2020.113275
  contributor:
    fullname: Hu
– volume: 1868
  start-page: 166320
  year: 2022
  ident: ref_52
  article-title: Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway
  publication-title: Biochim. et Biophys. Acta (BBA)-Mol. Basis Dis.
  doi: 10.1016/j.bbadis.2021.166320
  contributor:
    fullname: Jiang
– volume: 75
  start-page: 1627
  year: 2022
  ident: ref_5
  article-title: Cholestatic liver diseases of genetic etiology: Advances and controversies
  publication-title: Hepatology
  doi: 10.1002/hep.32437
  contributor:
    fullname: Ibrahim
– volume: 80
  start-page: 106179
  year: 2020
  ident: ref_22
  article-title: Prediction of triptolide targets in rheumatoid arthritis using network pharmacology and molecular docking
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2019.106179
  contributor:
    fullname: Song
– volume: 1
  start-page: a001651
  year: 2009
  ident: ref_47
  article-title: The nuclear factor NF-kappa B pathway in inflammation
  publication-title: Cold Spring Harb. Perspect. Biol.
  doi: 10.1101/cshperspect.a001651
  contributor:
    fullname: Lawrence
– volume: 34
  start-page: 3012
  year: 2019
  ident: ref_17
  article-title: Effect of the Junchen component of Lidan Mixture on dose-effect relationship of intrahepatic cholestasis in young rats
  publication-title: China J. Tradit. Chin. Med. Pharm.
  contributor:
    fullname: Zhang
– volume: 23
  start-page: 3951
  year: 2019
  ident: ref_39
  article-title: A study of regulatory effects of TLR4 and NF-κB on primary biliary cholangitis
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
  contributor:
    fullname: Yu
– volume: 187
  start-page: 144
  year: 2021
  ident: ref_70
  article-title: Relaxin in hepatic fibrosis: What is known and where to head?
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2021.06.001
  contributor:
    fullname: Ezhilarasan
– volume: 154
  start-page: 1
  year: 2009
  ident: ref_72
  article-title: Relaxin and its role in the development and treatment of fibrosis
  publication-title: Transl. Res.
  doi: 10.1016/j.trsl.2009.03.007
  contributor:
    fullname: Bennett
– volume: 26
  start-page: 1139
  year: 1996
  ident: ref_44
  article-title: The macrophage cell surface glycoprotein F4/80 is a highly glycosylated proteoglycan
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.1830260527
  contributor:
    fullname: Haidl
– volume: 58
  start-page: 587
  year: 2022
  ident: ref_65
  article-title: HIF-1alpha-pathway activation in cholangiocytes of patients with biliary atresia: An immunohistochemical/molecular exploratory study
  publication-title: J. Pediatr. Surg.
  doi: 10.1016/j.jpedsurg.2022.08.020
  contributor:
    fullname: Quelhas
– volume: 25
  start-page: 75
  year: 2018
  ident: ref_2
  article-title: Jaundice revisited: Recent advances in the diagnosis and treatment of inherited cholestatic liver diseases
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-018-0475-8
  contributor:
    fullname: Chen
– volume: 33
  start-page: 12435
  year: 2019
  ident: ref_71
  article-title: Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis
  publication-title: FASEB J.
  doi: 10.1096/fj.201901046R
  contributor:
    fullname: Kaftanovskaya
– volume: 12
  start-page: 618522
  year: 2021
  ident: ref_26
  article-title: Network pharmacology and pharmacological evaluation reveals the mechanism of the sanguisorba officinalis in suppressing hepatocellular carcinoma
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2021.618522
  contributor:
    fullname: Jiang
– volume: 108
  start-page: 154517
  year: 2023
  ident: ref_36
  article-title: Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2022.154517
  contributor:
    fullname: Xue
– volume: 43
  start-page: 491
  year: 2011
  ident: ref_56
  article-title: Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis
  publication-title: Int. Urol. Nephrol.
  doi: 10.1007/s11255-009-9683-1
  contributor:
    fullname: Rysz
– volume: 84
  start-page: 1204
  year: 2019
  ident: ref_67
  article-title: Prolactin signaling pathways determining its direct effects on kidneys in the cholestasis of pregnancy model
  publication-title: Biochemistry
  contributor:
    fullname: Abramicheva
– volume: 43
  start-page: 136
  year: 2021
  ident: ref_21
  article-title: Network pharmacology: Curing causal mechanisms instead of treating symptoms
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2021.11.004
  contributor:
    fullname: Nogales
– volume: 19
  start-page: 1185
  year: 2018
  ident: ref_59
  article-title: Melatonin ameliorates ANIT-induced cholestasis by activating Nrf2 through a PI3K/Akt-dependent pathway in rats
  publication-title: Mol. Med. Rep.
  contributor:
    fullname: Li
– volume: 90
  start-page: 107402
  year: 2020
  ident: ref_24
  article-title: A comprehensive application: Molecular docking and network pharmacology for the prediction of bioactive constituents and elucidation of mechanisms of action in component-based Chinese medicine
  publication-title: Comput. Biol. Chem.
  doi: 10.1016/j.compbiolchem.2020.107402
  contributor:
    fullname: Jiao
– volume: 181
  start-page: 221
  year: 2022
  ident: ref_57
  article-title: Omeprazole prevents stress induced gastric ulcer by direct inhibition of MMP-2/TIMP-3 interactions
  publication-title: Free. Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2022.02.007
  contributor:
    fullname: Rudra
– volume: 25
  start-page: 218
  year: 2022
  ident: ref_25
  article-title: Progress and prospects of research ideas and methods in the network pharmacology of traditional Chinese medicine
  publication-title: J. Pharm. Pharm. Sci.
  doi: 10.18433/jpps32911
  contributor:
    fullname: Yuan
– volume: 24
  start-page: 2236
  year: 1996
  ident: ref_50
  article-title: Inhibition of NF-kappaB DNA binding by nitric oxide
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/24.12.2236
  contributor:
    fullname: Matthews
– volume: 37
  start-page: 1
  year: 2009
  ident: ref_32
  article-title: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkn923
  contributor:
    fullname: Huang
– volume: 12
  start-page: 672054
  year: 2021
  ident: ref_27
  article-title: Therapeutic effects of naringin in rheumatoid arthritis: Network pharmacology and experimental validation
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2021.672054
  contributor:
    fullname: Aihaiti
– volume: 36
  start-page: 473
  year: 2015
  ident: ref_62
  article-title: The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/aps.2014.155
  contributor:
    fullname: Yu
– volume: 31
  start-page: 526
  year: 2017
  ident: ref_42
  article-title: Epigallocatechin-3-gallate ameliorates intrahepatic cholestasis of pregnancy by inhibiting matrix metalloproteinase-2 and matrix metalloproteinase-9
  publication-title: Fundam. Clin. Pharmacol.
  doi: 10.1111/fcp.12294
  contributor:
    fullname: Zhang
– ident: ref_14
  doi: 10.3390/nu13082901
– volume: 4
  start-page: 682
  year: 2008
  ident: ref_19
  article-title: Network pharmacology: The next paradigm in drug discovery
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.118
  contributor:
    fullname: Hopkins
– volume: 35
  start-page: 953
  year: 2019
  ident: ref_13
  article-title: Artemisinin bioactivity and resistance in malaria parasites
  publication-title: Trends Parasitol.
  doi: 10.1016/j.pt.2019.09.005
  contributor:
    fullname: Talman
– volume: 90
  start-page: 844
  year: 2010
  ident: ref_45
  article-title: The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice
  publication-title: Lab. Investig.
  doi: 10.1038/labinvest.2010.61
  contributor:
    fullname: Fickert
– volume: 17
  start-page: 1486
  year: 2015
  ident: ref_16
  article-title: Study on the antipyretic and cholagogic effects of gardenia and forsythia
  publication-title: World Sci. Technol.—Mod. Tradit. Chin. Med. Mater. Med.
  contributor:
    fullname: Meng
– volume: 13
  start-page: 63
  year: 2021
  ident: ref_18
  article-title: Clinical study on the treatment of mild intrahepatic cholestasis of pregnancy with artemisia capillaris and ephedra, forsythia and red bean decoction
  publication-title: Chin. J. Fam. Plan. Gynecotokology
  contributor:
    fullname: Xu
– volume: 9
  start-page: 5061
  year: 2015
  ident: ref_60
  article-title: Paeonia lactiflora Pall. protects against ANIT-induced cholestasis by activating Nrf2 via PI3K/Akt signaling pathway
  publication-title: Drug Des. Dev. Ther.
  doi: 10.2147/DDDT.S90030
  contributor:
    fullname: Zhao
– volume: 18
  start-page: 151
  year: 2020
  ident: ref_55
  article-title: Molecular and cellular mechanisms of liver fibrosis and its regression
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/s41575-020-00372-7
  contributor:
    fullname: Kisseleva
– volume: 11
  start-page: 110
  year: 2013
  ident: ref_20
  article-title: Traditional Chinese medicine network pharmacology: Theory, methodology and application
  publication-title: Chin. J. Nat. Med.
  doi: 10.3724/SP.J.1009.2013.00110
  contributor:
    fullname: Li
– volume: 65
  start-page: 37
  year: 2019
  ident: ref_54
  article-title: Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
  publication-title: Mol. Asp. Med.
  doi: 10.1016/j.mam.2018.09.002
  contributor:
    fullname: Parola
– volume: 148
  start-page: 758
  year: 2009
  ident: ref_69
  article-title: Effect of prolactin on excretory function of the liver during the induction and relief of cholestasis in female rats
  publication-title: Bull. Exp. Biol. Med.
  doi: 10.1007/s10517-010-0810-x
  contributor:
    fullname: Kushnareva
– volume: 615
  start-page: 121480
  year: 2022
  ident: ref_37
  article-title: PF-PLC micelles ameliorate cholestatic liver injury via regulating TLR4/MyD88/NF-κB and PXR/CAR/UGT1A1 signaling pathways in EE-induced rats
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2022.121480
  contributor:
    fullname: Yuan
– volume: 4
  start-page: 44
  year: 2009
  ident: ref_31
  article-title: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2008.211
  contributor:
    fullname: Huang
– volume: 375
  start-page: 631
  year: 2016
  ident: ref_6
  article-title: A placebo-controlled trial of obeticholic acid in primary biliary cholangitis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1509840
  contributor:
    fullname: Nevens
– volume: 60
  start-page: 503
  year: 2020
  ident: ref_8
  article-title: Drug therapies for chronic cholestatic liver diseases
  publication-title: Annu. Rev. Pharmacol. Toxicol.
  doi: 10.1146/annurev-pharmtox-010818-021059
  contributor:
    fullname: Wagner
– volume: 51
  start-page: 836
  year: 2020
  ident: ref_43
  article-title: Based on network pharmacology and molecular docking method, the research on the active compounds of Dayuan Decoction in the treatment of novel coronavirus pneumonia (COVID-19)
  publication-title: Chin. Tradit. Herb. Drugs
  contributor:
    fullname: Zong
– volume: 277
  start-page: 1845
  year: 2002
  ident: ref_48
  article-title: MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109910200
  contributor:
    fullname: Correia
– volume: 81
  start-page: 1181
  year: 2021
  ident: ref_3
  article-title: Cholestatic liver disease: Current treatment strategies and new therapeutic agents
  publication-title: Drugs
  doi: 10.1007/s40265-021-01545-7
  contributor:
    fullname: Hasegawa
– volume: 7
  start-page: srep41038
  year: 2017
  ident: ref_66
  article-title: Reduction of hepatic fibrosis by overexpression of von Hippel–Lindau protein in experimental models of chronic liver disease
  publication-title: Sci. Rep.
  doi: 10.1038/srep41038
  contributor:
    fullname: Wang
– volume: 271
  start-page: 113890
  year: 2021
  ident: ref_63
  article-title: Hepatoprotective effect of forsythiaside a against acetaminophen-induced liver injury in zebrafish: Coupling network pharmacology with biochemical pharmacology
  publication-title: J. Ethnopharmacol.
  doi: 10.1016/j.jep.2021.113890
  contributor:
    fullname: Gong
– volume: 4
  start-page: 31
  year: 2007
  ident: ref_46
  article-title: Nuclear factor-kappaB: Activation and regulation during toll-like receptor signaling
  publication-title: Cell Mol. Immunol.
  contributor:
    fullname: Carmody
– volume: 62
  start-page: 635
  year: 2015
  ident: ref_51
  article-title: Fibrates and cholestasis
  publication-title: Hepatology
  doi: 10.1002/hep.27744
  contributor:
    fullname: Ghonem
– volume: 147
  start-page: 59
  year: 2015
  ident: ref_12
  article-title: Medicinal plants, human health and biodiversity: A broad review
  publication-title: Adv. Biochem. Eng. Biotechnol.
  contributor:
    fullname: Sen
– volume: 5
  start-page: 776
  year: 2007
  ident: ref_4
  article-title: Diagnosis and management of cholestatic liver disease
  publication-title: Clin. Gastroenterol. Hepatol.
  doi: 10.1016/j.cgh.2007.05.008
  contributor:
    fullname: Heathcote
– volume: 36
  start-page: 506
  year: 2018
  ident: ref_9
  article-title: Plants as sources of natural and recombinant anti-cancer agents
  publication-title: Biotechnol. Adv.
  doi: 10.1016/j.biotechadv.2018.02.002
  contributor:
    fullname: Buyel
– volume: 139
  start-page: 1481
  year: 2010
  ident: ref_1
  article-title: Pathogenesis of cholestatic liver disease and therapeutic approaches
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2010.09.004
  contributor:
    fullname: Hirschfield
– volume: 276
  start-page: 35530
  year: 2001
  ident: ref_49
  article-title: 15-deoxy-delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M104518200
– ident: ref_53
  doi: 10.3390/cells9020281
– volume: 92
  start-page: 107328
  year: 2021
  ident: ref_7
  article-title: An insight into the mechanism and molecular basis of dysfunctional immune response involved in cholestasis
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2020.107328
  contributor:
    fullname: Zou
– volume: 42
  start-page: W26
  year: 2014
  ident: ref_28
  article-title: SuperPred: Update on drug classification and target prediction
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gku477
  contributor:
    fullname: Nickel
SSID ssj0000070763
Score 2.4158769
Snippet Forsythia fruit, edible fruit of (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for alleviating...
Forsythia fruit, edible fruit of Forsythia suspensa (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for...
Forsythia fruit, edible fruit of Forsythia suspensa (Thunb.) Vahl, which has been found to be effective in treating cholestasis. However, its key component for...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2065
SubjectTerms Animals
Apoptosis
Bile ducts
Cancer
Cholangitis
Cholestasis
Cholestasis - drug therapy
Collagen
Disease prevention
Drugs
Extracellular matrix
Fibrosis
Forsythia
forsythia fruit
forsythoside A
Fruit
Fruits
Functional foods
Functional foods & nutraceuticals
Gallbladder diseases
Gelatinase A
Herbal medicine
Inflammation
Injury prevention
Ligands
Liver
Liver diseases
Metabolites
Mice
Molecular docking
Molecular Docking Simulation
MyD88 protein
Network Pharmacology
NF-kappa B
NF-κB protein
Pharmacology
Pruritus
Software
Synaptotagmin
TLR4 protein
TLR4/NF-κB pathway
Toll-Like Receptor 4 - genetics
Toll-like receptors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT1wQUD4CBRmB4BQ1ayd2ctxWrAqiPbVSb5E9ttUgka12s4f9P_xQZpxkm4gDF66xnTie8cybZPyGsU-lVc4GXaS5y32KVtKkNisg9crk1tlc5Y7ODl9eqYub_PttcTsp9UU5YT09cL9wp2ByU4FEP1xWuYGA7sVYuXBBGoUNIVrfTEyCqR74agzQZc9HKjGuP213CH0qkZEXmXigSNT_tzme-KN5ruTE-ayesicDauTLfrbP2CPfPmfHyxYj5l97_pnHPM74gfyY_e7T6uKK83XgiPD45VgEl5-ZbbOly6v1Zrvv7hrDV5td0_GmjT1HSicca1rHr8c8dBpyTrV06QRSA_wH5XPwb-1PlAkfiv3wqz6nHKdz4MPex9s8PB-dGn2cf8FuVl-vzy_SoRZDCojpulQH6Y1ceMSXFjLpwWpRgIVQFd4pUBr3uRfgnUThZAG8LUWwmTCgyWZI-ZIdtevWv2YcMZaWwkHhNcKhgAKGxcIhyIccjFIhYR9H-dT3PeVGjaEKSbF-kGLCzkh0hx5Ekx0voPLUg_LU_1KehH0hwde0mVG6YIYzCThRosWql5r46yRiroSdzHriJoR586g69WAEtrVA8ETxaYnNHw7NNJIS21q_3lEfRBCVRjOfsFe9ph1eSSK6o3LrCStnOjh753lL29xFivDIy6aUfvM_VukteywQ2tE_NFGcsKNus_PvEIp19n3cdX8AIlg4IQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Coronavirus Research Database
  dbid: COVID
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWgvXDhq3wECjICwSntbpw4yQltF1YtouXSot4ie-zQgEjKJjksv4cfyoyT7G5A4sA1thNbeZ55tsdvGHuVaGl0Hkd-aELro5VUvp5E4FupQm10KENDd4dPz-TxRfjhMrrsN9zqPqxysInOUJsKaI_8MEBPRGQ_id5e__ApaxSdrvYpNG6yXYHUARG-O__0-eTdepfFqdlI0emSClzfH5YtUqA0mJA32fJETrD_b7O85ZfGMZNbTmhxh2VD97vYk28HbaMP4Ocfyo7_P7677HbPT_msA9Q9dsOW99nerMS1-fcVf81dxKjbit9jv7oAPvdveZVz5JL8dEi3y49UXdT0eFEt61VzVSi-WLZFw4vS1RzEo7CtKg0_HyLeqcmcsvbSXacC-EeKHOEn5Vf8-7xPK8TPuuh17M5aeXvlXrP5PrpPOgZ4wC4W78_nx36f9cEHZI-NH-fCKjG1yGQ1TIQFHQcRaMjTyBoJMkaLYgOwRmikpjlYnQS5ngQKYrJOQjxkO2VV2seMI5uLRWAgsjESrxxUCNOpweUEhKCkzD32ckBAdt2Je2S4KCKcZBuceOyIwLGuQYLc7kG1_JL18zvDd6sUBNLFJA0V5MiCFPbP5EJJLMBPvSFoZWQ2ED-g-tsP2FES4MpmMSnlCWR3Htsf1cTpDuPiAT9Zb27qbAMej71YF1NLCqErbdVSHeQqaYwOxWOPOiyvhySQR1Jid48lI5SPxjwuKYsrJ0buFOCkjJ_8u19P2a0A6SGdwwXRPttplq19hnSu0c_7OfsbwSlSyg
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwELZKkVAvFVAegYKMQHAK7NqJnRwQ2lasCmJ76kq9RX6lDQKnZLMS-3_4ocw4ybbhcc3YjpMZe75Jxt8Q8irTwupSpnFiExfDLqliPUlN7IRKtNWJSCyeHV6cipNl8vk8Pd8hQ_3O_gWu_hnaYT2pZfPt7c8fmw-w4N9jxAkh-zu_BlSTM3Cmt8htBh4RU7sWPczvYLCEcJ137KR_dNkjdzh4USxrPXJNgcH_7336hqMaJ1He8Erzu2S_h5N01un_Htlx_j45mHkIpb9v6GsaEjzDl_MD8qvLtwuqoHVJAfrRxVAdlx6pVbXCy_O6WW3ay0rRebOuWlr50HLgeoK-ylt6NiSoY5djLLKLR5MqQ79gogf95L-CsmhfBYiedsnmMJ0tUfYmDHN9f_B2-NX-AVnOP54dn8R9kYbYANhrY1lyp_jUAfDUZsKd0ZKlRpsyT50VRkjYABwzznINSLI0Tmes1BOmjMTNhPOHZNfX3j0mFMCX5Mya1EnASaVRiZlOLaB_kxglRBmRl4N-iquOi6OAGAYVWlwrNCJHqLptC-TPDhfq5qLol2MBY6vccEB3WZ4oUwJoUTA_W3IlQAC3eoOKL9DuQLtG9YcVYKLIl1XMJBLbcQBjETkctYTVacbiwXSKwbgLBqgKA9cMxC-2YuyJGW_e1WtsA9Ail7D_R-RRZ2nbRxoMNiLZyAZHzzyW-OoycIcHwjYh5JP_DvqU7DEAcvjHjKWHZLdt1u4ZAK9WPw-r6jdPNDAp
  priority: 102
  providerName: Scholars Portal
Title Exploration of the Molecular Basis of Forsythia Fruit in the Prevention and Treatment of Cholestatic Liver Injury through Network Pharmacology and Molecular Docking
URI https://www.ncbi.nlm.nih.gov/pubmed/37432229
https://www.proquest.com/docview/2812619285
https://search.proquest.com/docview/2836297376
https://pubmed.ncbi.nlm.nih.gov/PMC10180667
https://doaj.org/article/ca4a9c3125894acf853ab31df3a6a9cf
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe28cILAsZH2aiMQPCUtY0TO31sy8qGaJnQhvoW2ReHBa3u1I-H_j_8odw5SdeIN14SKWcnTs539zvnfMfYh8TIzOQqDqIssgFqSR2YbgyBlToymYlklNHe4clUXtxEX2fx7IDJei-MD9oHU5y5u_mZK259bOX9HDp1nFjnajLyWaekVJ1Ddoj2d89HL0GvQudclLlIBfr0HbdB2NMPu2RB9qyPT9L_ryres0XNOMk9wzN-yp5UiJEPypE9YwfWPWfHA4fe8nzLP3Ifw-kXx4_ZnzKkzn9tvsg5ojs-qQvg8qFeFSu6PF4sV9v1baH5eLkp1rxwvmWdzgn7apfx6zoGnbqMqI4u7T4qgH-jWA5-6X4jP3hV6IdPy3hyHM4uF_bW3-bh-WjQaGH-BbsZn1-PLoKqDkMAiOfWgcqF1aJnEVsa6AoLRoUxGMj7sc0kSIUybkOwmTAIFnOwJglz0w01KNIXQrxkR27h7GvGEV8pEWYQW4VQKAcdQa-XIcCHCLSUeYu9r_mT3pfpNlJ0U4iL6QMXW2xIrNu1oBTZ_sJi-SutJkqK99Z9EAjgkn6kIUdconF8WS60RAI-6hMxPiVBRu6CrvYj4EApJVY6UJS7TiDearHTRksUQGiS66mTVgpglYYInMg3TZD8bkemnhTU5uxiQ20QPfQVqvgWe1XOtN0rCUR2VGq9xZLGHGy8c5OC0uLTg9fS8eb_u56wxyGCOfprFsan7Gi93Ni3CL7Wpo0SN1Nt9mh4Pr36gefR95-Xn9t-KQOPX2Y9PE6ipO1l8i-VXDz0
link.rule.ids 230,314,727,780,784,864,885,2102,2221,12056,21388,24318,27924,27925,31719,31720,33744,33745,38516,43310,43805,43895,53791,53793,73745,74302,74412
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELage4ALr-URWMAIBKfstnHitCfULVQttOWyi_Zm2WOHDYhkadND-T38UGbyaBuQOHCN7cRWPs98tsffMPaqb6Q1SRz5oQ2dj1ZS-6Ybge-kDo01oQwt3R2eL-TkPPxwEV3UG26rOqyysYmlobY50B75SYCeiMh-P3p79cOnrFF0ulqn0LjODiiLd9RhB6NPn6fvtrsspZqNFJUuqcD1_Um2Rgo0CLrkTfY8USnY_7dZ3vNL7ZjJPSc0vs1U0_0q9uTb8bowx_DzD2XH_x_fHXar5qd8WAHqLrvmsnvscJjh2vz7hr_mZcRouRV_yH5VAXzlv-V5wpFL8nmTbpef6lW6osfjfLnaFJep5uPlOi14mpU1G_EobKszy8-aiHdqMqKsvXTXKQU-o8gRPs2-4t_ndVohvqii17E7W-XtTfma3ffRfdIxwH12Pn5_Npr4ddYHH5A9Fn6cCKdFzyGTNdAVDkwcRGAgGUTOSpAxWhQXgLPCIDVNwJl-kJhuoCEm6yTEA9bJ8sw9YhzZXCwCC5GLkXgloEPo9SwuJyAELWXisZcNAtRVJe6hcFFEOFE7nHjslMCxrUGC3OWDfPlF1fNb4bv1AATSxf4g1JAgC9LYP5sILbEAP_WGoKXIbCB-QNe3H7CjJMClhjEp5Qlkdx47atXE6Q7t4gY_qjY3K7UDj8debIupJYXQZS5fUx3kKoMYHYrHHlZY3g5JII-kxO4e67dQ3hpzuyRLL0sx8lIBTsr48b_79ZzdmJzNZ2o2XXx8wm4GSBXpTC6IjlinWK7dU6R2hXlWz9_f2OBVug
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lc9MwENZAOsNw4VUehgJiYODkNrFsyTkxaUqmgTZwaJneNHqZGga7JM4h_B5-KLuyncQww4GrJdnS-NPuJ2n1LSGvUs2tzkQSxjZ2IVhJFep-YkLHVaytjnls8e7w6Ywfn8fvL5KLZsNt0YRVtjbRG2pbGtwjP4jAEyHZT5O3Vz9CzBqFp6tNCo3rZEeAX496ZGf88fP0aL3L4tVsOKt1SRms7w-KJVCgYdRHb7Llibxg_99mecsvdWMmt5zQ5DaRbffr2JNv-8tK75uffyg7_v_47pBbDT-loxpQd8k1V9wju6MC1ubfV_Q19RGjfit-l_yqA_j8v6VlRoFL0tM23S49VIt8gY8n5Xyxqi5zRSfzZV7RvPA1W_EoaKsKS8_aiHdsMsasvXjXKTf0BCNH6LT4Cn-fNmmF6KyOXofurJW3V_41m--D-8RjgPvkfPLubHwcNlkfQgPssQpFxpxiAwdMVps-c0aLKDHaZMPEWW64AIviIuMs00BNM-N0GmW6Hykj0Dox9oD0irJwjwgFNidYZE3iBBCvzKjYDAYWlhMmNorzLCAvWwTIq1rcQ8KiCHEiNzgJyCGCY10DBbn9g3L-RTbzW8K71dAwoIvpMFYmAxakoH82Y4pDAXzqDUJLotkA_BjV3H6AjqIAlxwJVMpjwO4CstepCdPddItb_MjG3CzkBjwBebEuxpYYQle4col1gKsMBTiUgDyssbweEgMeiYndA5J2UN4Zc7ekyC-9GLlXgONcPP53v56TG5-OJvJkOvvwhNyMgCnikVyU7JFeNV-6p8DsKv2smb6_AVP3VVM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploration+of+the+Molecular+Basis+of+Forsythia+Fruit+in+the+Prevention+and+Treatment+of+Cholestatic+Liver+Injury+through+Network+Pharmacology+and+Molecular+Docking&rft.jtitle=Nutrients&rft.au=Fu%2C+Ke&rft.au=Li%2C+Yanzhi&rft.au=Dai%2C+Shu&rft.au=Li%2C+Yunxia&rft.date=2023-04-25&rft.eissn=2072-6643&rft.volume=15&rft.issue=9&rft_id=info:doi/10.3390%2Fnu15092065&rft_id=info%3Apmid%2F37432229&rft.externalDocID=37432229
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6643&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6643&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6643&client=summon